Rapid method finds potent COVID-19 monoclonal antibody among a trillion possibilities

Scientists have discovered the fastest way to identify potent, neutralizing human monoclonal antibodies against SARS-CoV-2, the virus that causes COVID-19. The method — as well as a trio of successful animal studies on an antibody called ‘Ab1’ — are described today in a new study. Ab1 is on track for human clinical trials by early next year.

About admin

Now Dr. Jack Straw is in charge of the website, and organizes it so that medical care is available to everyone. In addition, he is an active member of the medical community, regularly attending international conferences and sharing his experience and knowledge. Dr. Straw is not only a medical professional and website manager, but also a loving husband and father of his beautiful children.
View all posts by admin →

Leave a Reply

Your email address will not be published. Required fields are marked *